[Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)].
Otto-Knapp R, Bauer T, Brinkmann F, Feiterna-Sperling C, Friesen I, Geerdes-Fenge H, Hartmann P, Häcker B, Hauer B, Haas W, Heyckendorf J, Kuhns M, Lange C, Maurer F, Nienhaus A, Priwitzer M, Richter E, Salzer H, Schoch O, Schönfeld N, Schaberg T. [Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)]. Pneumologie 2023
06.11.2023
[Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)].
06.11.2023
Pneumologie 2023
Otto-Knapp Ralf, Bauer Torsten, Brinkmann Folke, Feiterna-Sperling Cornelia, Friesen Inna, Geerdes-Fenge Hilte, Hartmann Pia, Häcker Brit, Hauer Barbara, Haas Walter, Heyckendorf Jan, Kuhns Martin, Lange Christoph, Maurer Florian P, Nienhaus Albert, Priwitzer Martin, Richter Elvira, Salzer Helmut J F, Schoch Otto, Schönfeld Nicolas, Schaberg Tom
Weiter
